Market opportunities include enhancing medical device quality through robust process validation training, aligning with regulatory and QMS needs, and integrating GAMPv for improved data integrity.

In the highly regulated world of life sciences, quality isn’t a box to check—it’s a business imperative. For global ...

ValGenesis Inc., the market leader in digital validation lifecycle management, and Westbourne, a life sciences-focused IT services and engineering company, have formed a strategic partnership to ...

Seattle-based startup Iridius has raised $8.6 million in seed funding to automate regulatory compliance for AI systems in life sciences, particularly pharmaceuticals. Founded by Microsoft and AWS ...

ValGenesis, the market leader in digital validation lifecycle management, today announced the launch of the next generation of VALtm (ValGenesis AI), designed to help life sciences companies ...

ValGenesis to debut the next generation of VAL™ (ValGenesis AI) at INTERPHEX 2026. Visit booth 3552 for demos and pilot ...

Continuous human oversight across design, validation, and operational deployment is positioned as the primary control to ...

The company also highlighted Coimbatore’s growing role as an engineering hub, aligning with shifts underway in the global automotive ecosystem. Tata Technologies on Wednesday said it has expanded its ...

As AI and high‑performance computing systems continue to scale, memory bandwidth has emerged as a primary system‑level constraint. Larger models, higher compute density, and increasingly complex multi ...

Lets take a closer look at the current electronic quality management system (eQMS) landscape in pharma/biotech and what a ...

Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, today announced the Spring 2026 release of its RAM platform, introducing new capabilities ...